Investing Profile

Shahram Hejazi

InvestorVCCEO
Managing Director & CEO at BioAdvance
Photo of Shahram Hejazi, Managing Director at BioAdvance
cb
BioAdvance Managing Director
$1.5M - $5.0M
$3.3M
35
CompanyStageDateRound SizeTotal Raised
Halo Labs
Series CJul 2022$7M
Series BApr 2020$12M
Series BDec 2018$6M
SeedJun 2014
SeedNov 2013
SeedJun 2012$750K
SeedApr 2011
$26M
Ride Health
SeedJan 2020$6M
SeedMay 2017
$6M
Bainbridge Health
SeedJun 2018$2M
SeedJul 2016
$2M
Oncora Medical
SeedSep 2017$3M
SeedMar 2016$1M
$4M
Co-investors: Steve Barsh (GIT1K)
Genome Profiling
Series UnknownAug 2017$880K
SeedOct 2016
$880K
WellTrackONE
Series UnknownAug 2017$200K
Series AAug 2015$2M
$2.2M
TalexMedical
SeedAug 2017$500K
$500K
Keriton Inc
SeedFeb 2017$1M
$1M
Co-investors: Steve Barsh (GIT1K), Barbara Schilberg (BioAdvance), Darren Sandberg (DreamIt Ventures)
Research tools